185 related articles for article (PubMed ID: 21763262)
21. 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.
Finkelstein SD; Hasegawa T; Colby T; Yousem SA
Am J Pathol; 1999 Aug; 155(2):633-40. PubMed ID: 10433956
[TBL] [Abstract][Full Text] [Related]
22. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid.
Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M
J BUON; 2019; 24(1):256-266. PubMed ID: 30941978
[TBL] [Abstract][Full Text] [Related]
23. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.
Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E
J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341
[TBL] [Abstract][Full Text] [Related]
24. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
[TBL] [Abstract][Full Text] [Related]
25. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1.
Sigl E; Behmel A; Henn T; Wirnsberger G; Weinhausl A; Kaserer K; Niederle B; Pfragner R
Int J Oncol; 1999 Jul; 15(1):41-51. PubMed ID: 10375592
[TBL] [Abstract][Full Text] [Related]
27. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
Jonkers YM; Claessen SM; Feuth T; van Kessel AG; Ramaekers FC; Veltman JA; Speel EJ
J Pathol; 2006 Dec; 210(4):450-8. PubMed ID: 17068744
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
29. DNA cytophotometry and prognosis in typical and atypical bronchopulmonary carcinoids. A clinicomorphologic study of 100 neuroendocrine lung tumors.
Padberg BC; Woenckhaus J; Hilger G; Beccu L; Jochum W; Range U; Kastendieck H; Schröder S
Am J Surg Pathol; 1996 Jul; 20(7):815-22. PubMed ID: 8669529
[TBL] [Abstract][Full Text] [Related]
30. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.
Alcala N; Leblay N; Gabriel AAG; Mangiante L; Hervas D; Giffon T; Sertier AS; Ferrari A; Derks J; Ghantous A; Delhomme TM; Chabrier A; Cuenin C; Abedi-Ardekani B; Boland A; Olaso R; Meyer V; Altmuller J; Le Calvez-Kelm F; Durand G; Voegele C; Boyault S; Moonen L; Lemaitre N; Lorimier P; Toffart AC; Soltermann A; Clement JH; Saenger J; Field JK; Brevet M; Blanc-Fournier C; Galateau-Salle F; Le Stang N; Russell PA; Wright G; Sozzi G; Pastorino U; Lacomme S; Vignaud JM; Hofman V; Hofman P; Brustugun OT; Lund-Iversen M; Thomas de Montpreville V; Muscarella LA; Graziano P; Popper H; Stojsic J; Deleuze JF; Herceg Z; Viari A; Nuernberg P; Pelosi G; Dingemans AMC; Milione M; Roz L; Brcic L; Volante M; Papotti MG; Caux C; Sandoval J; Hernandez-Vargas H; Brambilla E; Speel EJM; Girard N; Lantuejoul S; McKay JD; Foll M; Fernandez-Cuesta L
Nat Commun; 2019 Aug; 10(1):3407. PubMed ID: 31431620
[TBL] [Abstract][Full Text] [Related]
31. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis.
Zhao J; de Krijger RR; Meier D; Speel EJ; Saremaslani P; Muletta-Feurer S; Matter C; Roth J; Heitz PU; Komminoth P
Am J Pathol; 2000 Nov; 157(5):1431-8. PubMed ID: 11073802
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
33. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors.
Kovatich A; Friedland DM; Druck T; Hadaczek P; Huebner K; Comis RL; Hauck W; McCue PA
Cancer; 1998 Sep; 83(6):1109-17. PubMed ID: 9740075
[TBL] [Abstract][Full Text] [Related]
34. Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study.
Tyybäkinoja A; Saarinen-Pihkala U; Elonen E; Knuutila S
Genes Chromosomes Cancer; 2006 Mar; 45(3):257-64. PubMed ID: 16283618
[TBL] [Abstract][Full Text] [Related]
35. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.
Stilgenbauer S; Liebisch P; James MR; Schröder M; Schlegelberger B; Fischer K; Bentz M; Lichter P; Döhner H
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11837-41. PubMed ID: 8876224
[TBL] [Abstract][Full Text] [Related]
36. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
[TBL] [Abstract][Full Text] [Related]
37. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].
Słodkowska J; Langfort R; Rudziński P; Kupis W
Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650
[TBL] [Abstract][Full Text] [Related]
38. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
[TBL] [Abstract][Full Text] [Related]
39. Distinctive pathological and clinical features of lung carcinoids with high proliferation index.
Marchiò C; Gatti G; Massa F; Bertero L; Filosso P; Pelosi G; Cassoni P; Volante M; Papotti M
Virchows Arch; 2017 Dec; 471(6):713-720. PubMed ID: 28631159
[TBL] [Abstract][Full Text] [Related]
40. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors.
Wang GG; Yao JC; Worah S; White JA; Luna R; Wu TT; Hamilton SR; Rashid A
Mod Pathol; 2005 Aug; 18(8):1079-87. PubMed ID: 15920555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
